The metabolic enzyme fatty acid synthase (FASN) is responsible for the endogenous synthesis of palmitate, a saturated long-chain fatty acid. In contrast to most normal tissues, a variety of human cancers overexpress FASN. One such cancer is cutaneous melanoma, in which the level of FASN expression is associated with tumor invasion and poor prognosis. We previously reported that two FASN inhibitors, cerulenin and orlistat, induce apoptosis in B16-F10 mouse melanoma cells via the intrinsic apoptosis pathway. Here, we investigated the effects of these inhibitors on non-tumorigenic melan-a cells. Cerulenin and orlistat treatments were found to induce apoptosis and decrease cell proliferation, in addition to inducing the release of mitochondrial cytochrome c and activating caspases-9 and -3. Transfection with FASN siRNA did not result in apoptosis. Mass spectrometry analysis demonstrated that treatment with the FASN inhibitors did not alter either the mitochondrial free fatty acid content or composition. This result suggests that cerulenin- and orlistat-induced apoptosis events are independent of FASN inhibition. Analysis of the energy-linked functions of melan-a mitochondria demonstrated the inhibition of respiration, followed by a significant decrease in mitochondrial membrane potential (Δψm) and the stimulation of superoxide anion generation. The inhibition of NADH-linked substrate oxidation was approximately 40% and 61% for cerulenin and orlistat treatments, respectively, and the inhibition of succinate oxidation was approximately 46% and 52%, respectively. In contrast, no significant inhibition occurred when respiration was supported by the complex IV substrate N,N,N',N'-tetramethyl-p-phenylenediamine (TMPD). The protection conferred by the free radical scavenger N-acetyl-cysteine indicates that the FASN inhibitors induced apoptosis through an oxidative stress-associated mechanism. In combination, the present results demonstrate that cerulenin and orlistat induce apoptosis in non-tumorigenic cells via mitochondrial dysfunction, independent of FASN inhibition. © 2014 Rossato et al.96 Baron, A., Migita, T., Tang, D., Loda, M., Fatty acid synthase: A metabolic oncogene in prostate cancer? (2004) Journal of Cellular Biochemistry, 91, pp. 47-53Chirala, S.S., Jayakumar, A., Gu, Z.-W., Wakil, S.J., Human fatty acid synthase: Role of interdomain in the formation of catalytically active synthase dimer (2001) Proceedings of the National Academy of Sciences of the United States of America, 98 (6), pp. 3104-3108. , DOI 10.1073/pnas.051635998Kuhajda, F.P., Pizer, E.S., Li, J.N., Mani, N.S., Frehywot, G.L., Townsend, C.A., Synthesis and antitumor activity of an inhibitor of fatty acid synthase (2000) Proceedings of the National Academy of Sciences of the United States of America, 97 (7), pp. 3450-3454. , DOI 10.1073/pnas.050582897Menendez, J.A., Lupu, R., Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis (2007) Nature Reviews, 7, pp. 763-777Rangan, V.S., Joshi, A.K., Smith, S., Mapping the functional topology of the animal fatty acid synthase by mutant complementation in vitro (2001) Biochemistry, 40 (36), pp. 10792-10799. , DOI 10.1021/bi015535zStoops, J.K., Wakil, S.J., Animal fatty acid synthetase. A novel arrangement of the beta-ketoacyl synthetase sites comprising domains of the two subunits (1981) The Journal of Biological Chemistry, 256, pp. 5128-5133Tsukamoto, Y., Wong, H., Mattick, J.S., Wakil, S.J., The architecture of the animal fatty acid synthetase complex. IV. Mapping of active centers and model for the mechanism of action (1983) The Journal of Biological Chemistry, 258, pp. 15312-15322Chirala, S.S., Chang, H., Matzuk, M., Abu-Elheiga, L., Mao, J., Mahon, K., Finegold, M., Wakil, S.J., Fatty acid synthesis is essential in embryonic development: Fatty acid synthase null mutants and most of the heterozygotes die in utero (2003) Proceedings of the National Academy of Sciences of the United States of America, 100 (11), pp. 6358-6363. , DOI 10.1073/pnas.0931394100Kumar-Sinha, C., Ignatoski, K.W., Lippman, M.E., Ethier, S.P., Chinnaiyan, A.M., Transcriptome analysis of HER2 reveals a molecular connection to fatty acid synthesis (2003) Cancer Research, 63 (1), pp. 132-139Kusakabe, T., Nashimoto, A., Honma, K., Suzuki, T., Fatty acid synthase is highly expressed in carcinoma, adenoma and in regenerative epithelium and intestinal metaplasia of the stomach (2002) Histopathology, 40 (1), pp. 71-79. , DOI 10.1046/j.1365-2559.2002.01289.xWeiss, L., Hoffmann, G.E., Schreiber, R., Andres, H., Fuchs, E., Fatty-acid biosynthesis in man, a pathway of minor importance. Purification, optimal assay conditions, and organ distribution of fatty-acid synthase (1986) Biological Chemistry Hoppe-Seyler, 367, pp. 905-912Agostini, M., Silva, S.D., Zecchin, K.G., Coletta, R.D., Jorge, J., Loda, M., Graner, E., Fatty acid synthase is required for the proliferation of human oral squamous carcinoma cells (2004) Oral Oncology, 40 (7), pp. 728-735. , DOI 10.1016/j.oraloncology.2004.01.011, PII S1368837504000272Alo, P.L., Visca, P., Framarino, M.L., Botti, C., Monaco, S., Immunohistochemical study of fatty acid synthase in ovarian neoplasms (2000) Oncology Reports, 7, pp. 1383-1388Da Silva, S.D., Cunha, I.W., Nishimoto, I.N., Soares, F.A., Carraro, D.M., Clinicopathological significance of ubiquitin-specific protease 2a (USP2a), fatty acid synthase (FASN), and ErbB2 expression in oral squamous cell carcinomas (2009) Oral Oncology, 45, pp. e134-e139Dowling, S., Cox, J., Cenedella, R.J., Inhibition of fatty acid synthase by Orlistat accelerates gastric tumor cell apoptosis in culture and increases survival rates in gastric tumor bearing mice in vivo (2009) Lipids, 44, pp. 489-498Innocenzi, D., Alo, P.L., Balzani, A., Sebastiani, V., Silipo, V., La, T.G., Ricciardi, G., Calvieri, S., Fatty acid synthase expression in melanoma (2003) Journal of Cutaneous Pathology, 30 (1), pp. 23-28. , DOI 10.1034/j.1600-0560.2003.300104.xKapur, P., Rakheja, D., Roy, L.C., Hoang, M.P., Fatty acid synthase expression in cutaneous melanocytic neoplasms (2005) Modern Pathology, 18 (8), pp. 1107-1112. , DOI 10.1038/modpathol.3800395Krontiras, H., Roye, G.D., Beenken, S.E., Myers, R.B., Mayo, M.S., Peters, G.E., Grizzle, W.E., Fatty acid synthase expression is increased in neoplastic lesions of the oral tongue (1999) Head and Neck, 21 (4), pp. 325-329. , DOI 10.1002/(SICI)1097-0347(199907)21:4<325::AID-HMilgraum, L.Z., Witters, L.A., Pasternack, G.R., Kuhajda, F.P., Enzymes of the fatty acid synthesis pathway are highly expressed in in situ breast carcinoma (1997) Clinical Cancer Research, 3 (11), pp. 2115-2120Nemoto, T., Terashima, S., Kogure, M., Hoshino, Y., Kusakabe, T., Suzuki, T., Gotoh, M., Overexpression of fatty acid synthase in oesophageal squamous cell dysplasia and carcinoma (2001) Pathobiology, 69 (6), pp. 297-303. , DOI 10.1159/000064636Ogino, S., Nosho, K., Meyerhardt, J.A., Kirkner, G.J., Chan, A.T., Cohort study of fatty acid synthase expression and patient survival in colon cancer (2008) J Clin Oncol, 26, pp. 5713-5720Piyathilake, C.J., Frost, A.R., Manne, U., Bell, W.C., Weiss, H., The expression of fatty acid synthase (FASE) is an early event in the development and progression of squamous cell carcinoma of the lung (2000) Human Pathology, 31, pp. 1068-1073Pizer, E.S., Chrest, F.J., DiGiuseppe, J.A., Han, W.F., Pharmacological inhibitors of mammalian fatty acid synthase suppress DNA replication and induce apoptosis in tumor cell lines (1998) Cancer Research, 58 (20), pp. 4611-4615Rossi, S., Ou, W., Tang, D., Bhattacharya, N., Dei, T.A.P., Fletcher, J.A., Loda, M., Gastrointestinal stromal tumours overexpress fatty acid synthase (2006) Journal of Pathology, 209 (3), pp. 369-375. , DOI 10.1002/path.1983Silva, S.D., Agostini, M., Nishimoto, I.N., Coletta, R.D., Alves, F.A., Lopes, M.A., Kowalski, L.P., Graner, E., Expression of fatty acid synthase, ErbB2 and Ki-67 in head and neck squamous cell carcinoma. A clinicopathological study (2004) Oral Oncology, 40 (7), pp. 688-696. , DOI 10.1016/j.oraloncology.2004.01.004, PII S1368837504000077Silva, S.D., Cunha, I.W., Rangel, A.L., Jorge, J., Zecchin, K.G., Differential expression of fatty acid synthase (FAS) and ErbB2 in nonmalignant and malignant oral keratinocytes (2008) Virchows Arch, 453, pp. 57-67Swinnen, J.V., Roskams, T., Joniau, S., Van Poppel, H., Oyen, R., Baert, L., Heyns, W., Verhoeven, G., Overexpression of fatty acid synthase is an early and common event in the development of prostate cancer (2002) International Journal of Cancer, 98 (1), pp. 19-22. , DOI 10.1002/ijc.10127Takahiro, T., Shinichi, K., Toshimitsu, S., Expression of fatty acid synthase as a prognostic indicator in soft tissue sarcomas (2003) Clinical Cancer Research, 9 (6), pp. 2204-2212Ueda, S.M., Yap, K.L., Davidson, B., Tian, Y., Murthy, V., Expression of Fatty Acid Synthase Depends on NAC1 and Is Associated with Recurrent Ovarian Serous Carcinomas (2010) J Oncol, 2010, p. 285191Visca, P., Alo, P.L., Del, N.F., Botti, C., Trombetta, G., Marandino, F., Filippi, S., Donnorso, R.P., Immunohistochemical expression of fatty acid synthase, apoptotic- regulating genes, proliferating factors, and ras protein product in colorectal adenomas, carcinomas, and adjacent nonneoplastic mucosa (1999) Clinical Cancer Research, 5 (12), pp. 4111-4118Visca, P., Sebastiani, V., Pizer, E.S., Botti, C., De Carli, P., Filippi, S., Monaco, S., Alo, P.L., Immunohistochemical expression and prognostic significance of FAS and GLUT1 in bladder carcinoma (2003) Anticancer Research, 23 (1 A), pp. 335-339Vlad, L.D., Axiotis, C.A., Merino, M.J., Green, W., Fatty Acid Synthase is Highly Expressed in Aggressive Thyroid Tumors (1999) Mod Pathol, 12, p. 70Walter, K., Hong, S.M., Nyhan, S., Canto, M., Fedarko, N., Serum fatty acid synthase as a marker of pancreatic neoplasia (2009) Cancer Epidemiol Biomarkers Prev, 18, pp. 2380-2385Epstein, J.I., Carmichael, M., Partin, A.W., OA-519 (fatty acid synthase) as an independent predictor of pathologic state in adenocarcinoma of the prostate (1995) Urology, 45, pp. 81-86Gansler, T.S., Hardman III, W., Hunt, D.A., Schaffel, S., Hennigar, R.A., Increased expression of fatty acid synthase (OA-519) in ovarian neoplasms predicts shorter survival (1997) Human Pathology, 28 (6), pp. 686-692. , DOI 10.1016/S0046-8177(97)90177-5Kuhajda, F.P., Fatty-acid synthase and human cancer: New perspectives on its role in tumor biology (2000) Nutrition Burbank, Los Angeles County, Calif, 16, pp. 202-208Liu, X., Shi, Y., Giranda, V.L., Luo, Y., Inhibition of the phosphatidylinositol 3-kinase/Akt pathway sensitizes MDA-MB468 human breast cancer cells to cerulenin-induced apoptosis (2006) Molecular Cancer Therapeutics, 5, pp. 494-501Rossi, S., Graner, E., Febbo, P., Weinstein, L., Bhattacharya, N., Onody, T., Bubley, G., Loda, M., Fatty acid synthase expression defines distinct molecular signatures in prostate cancer (2003) Molecular Cancer Research, 1 (10), pp. 707-715Kridel, S.J., Axelrod, F., Rozenkrantz, N., Smith, J.W., Orlistat Is a Novel Inhibitor of Fatty Acid Synthase with Antitumor Activity (2004) Cancer Research, 64 (6), pp. 2070-2075. , DOI 10.1158/0008-5472.CAN-03-3645Pizer, E.S., Jackisch, C., Wood, F.D., Pasternack, G.R., Davidson, N.E., Kuhajda, F.P., Inhibition of fatty acid synthesis induces programmed cell death in human breast cancer cells (1996) Cancer Research, 56 (12), pp. 2745-2747Pizer, E.S., Wood, F.D., Heine, H.S., Romantsev, F.E., Pasternack, G.R., Kuhajda, F.P., Inhibition of fatty acid synthesis delays disease progression in a xenograft model of ovarian cancer (1996) Cancer Research, 56 (6), pp. 1189-1193Bandyopadhyay, S., Zhan, R., Wang, Y., Pai, S.K., Hirota, S., Hosobe, S., Takano, Y., Watabe, K., Mechanism of apoptosis induced by the inhibition of fatty acid synthase in breast cancer cells (2006) Cancer Research, 66 (11), pp. 5934-5940. , DOI 10.1158/0008-5472.CAN-05-3197Zhang, J.-H., Zhang, Y., Herman, B., Caspases, apoptosis and aging (2003) Ageing Research Reviews, 2 (4), pp. 357-366. , DOI 10.1016/S1568-1637(03)00026-6Heiligtag, S.J., Bredehorst, R., David, K.A., Key role of mitochondria in cerulenin-mediated apoptosis (2002) Cell Death and Differentiation, 9 (9), pp. 1017-1025. , DOI 10.1038/sj.cdd.4401055Li, J.-N., Gorospe, M., Chrest, F.J., Kumaravel, T.S., Evans, M.K., Han, W.F., Pizer, E.S., Pharmacological inhibition of fatty acid synthase activity produces both cytostatic and cytotoxic effects modulated by p53 (2001) Cancer Research, 61 (4), pp. 1493-1499Carvalho, M.A., Zecchin, K.G., Seguin, F., Bastos, D.C., Agostini, M., Fatty acid synthase inhibition with Orlistat promotes apoptosis and reduces cell growth and lymph node metastasis in a mouse melanoma model (2008) International Journal of Cancer, 123, pp. 2557-2565Zecchin, K.G., Rossato, F.A., Raposo, H.F., Melo, D.R., Alberici, L.C., Inhibition of fatty acid synthase in melanoma cells activates the intrinsic pathway of apoptosis (2010) Lab Invest, 91, pp. 232-240Seguin, F., Carvalho, M.A., Bastos, D.C., Agostini, M., Zecchin, K.G., The fatty acid synthase inhibitor orlistat reduces experimental metastases and angiogenesis in B16-F10 melanomas (2012) British Journal of Cancer, 107, pp. 977-987Zecchin, K.G., Alberici, L.C., Riccio, M.F., Eberlin, M.N., Vercesi, A.E., Visualizing inhibition of fatty acid synthase through mass spectrometric analysis of mitochondria from melanoma cells (2011) Rapid Commun Mass Spectrom, 25, pp. 449-452Pizer, E.S., Pflug, B.R., Bova, G.S., Han, W.F., Udan, M.S., Increase fatty acid synthase as a therapeutic target in androgen independent prostate cancer progression (2000) Proceedings of the American Association for Cancer Research, 41, p. 655Pizer, E.S., Thupari, J., Han, W.F., Pinn, M.L., Chrest, F.J., Frehywot, G.L., Townsend, C.A., Kuhajda, F.P., Malonyl-coenzyme-A is a potential mediator of cytotoxicity induced by fatty-acid synthase inhibition in human breast cancer cells and xenografts (2000) Cancer Research, 60 (2), pp. 213-218Deepa, P.R., Vandhana, S., Jayanthi, U., Krishnakumar, S., Therapeutic and toxicologic evaluation of anti-lipogenic agents in cancer cells compared with non-neoplastic cells (2012) Basic Clin Pharmacol Toxicol, 110, pp. 494-503Almeida, J.P., Coletta, R.D., Silva, S.D., Agostini, M., Vargas, P.A., Bozzo, L., Graner, E., Proliferation of fibroblasts cultured from normal gingiva and hereditary gingival fibromatosis is dependent on fatty acid synthase activity (2005) Journal of Periodontology, 76 (2), pp. 272-278. , DOI 10.1902/jop.2005.76.2.272Browne, C.D., Hindmarsh, E.J., Smith, J.W., Inhibition of endothelial cell proliferation and angiogenesis by orlistat, a fatty acid synthase inhibitor (2006) FASEB Journal, 20 (12), pp. 2027-2035. , http://www.fasebj.org/cgi/reprint/20/12/2027.pdf, DOI 10.1096/fj.05-5404comBennett, D.C., Cooper, P.J., Hart, I.R., A line of non-tumorigenic mouse melanocytes, syngeneic with the B16 melanoma and requiring a tumour promoter for growth (1987) International Journal of Cancer, 39 (3), pp. 414-418. , DOI 10.1002/ijc.2910390324Richardson, R.D., Smith, J.W., Novel antagonists of the thioesterase domain of human fatty acid synthase (2007) Molecular Cancer Therapeutics, 6 (7), pp. 2120-2126. , http://mct.aacrjournals.org/cgi/reprint/6/7/2120.pdf, DOI 10.1158/1535-7163.MCT-07-0187Knowles, L.M., Axelrod, F., Browne, C.D., Smith, J.W., A fatty acid synthase blockade induces tumor cell-cycle arrest by down-regulating Skp2 (2004) Journal of Biological Chemistry, 279 (29), pp. 30540-30545. , DOI 10.1074/jbc.M405061200Payne, C.M., Weber, C., Crowley-Skillicorn, C., Dvorak, K., Bernstein, H., Bernstein, C., Holubec, H., Garewal, H., Deoxycholate induces mitochondrial oxidative stress and activates NF-kappaB through multiple mechanisms in HCT-116 colon epithelial cells (2007) Carcinogenesis, 28 (1), pp. 215-222. , DOI 10.1093/carcin/bgl139Zecchin, K.G., Seidinger, A.L.O., Chiaratti, M.R., Degasperi, G.R., Meirelles, F.V., Castilho, R.F., Vercesi, A.E., High Bcl-2/Bax ratio in Walker tumor cells protects mitochondria but does not prevent H2O2-induced apoptosis via calcineurin pathways (2007) Journal of Bioenergetics and Biomembranes, 39 (2), pp. 186-194. , DOI 10.1007/s10863-007-9076-zCampos, C.B.L., Paim, B.A., Cosso, R.G., Castilho, R.F., Rottenberg, H., Vercesi, A.E., Method for monitoring of mitochondrial cytochrome c release during cell death: Immunodetection of cytochrome c by flow cytometry after selective permeabilization of the plasma membrane (2006) Cytometry Part A, 69 (6), pp. 515-523. , DOI 10.1002/cyto.a.20273Holden, M.J., Sze, H., Effects of Helminthosporium maydis Race T Toxin on Electron Transport in Susceptible Corn Mitochondria and Prevention of Toxin Actions by Dicyclohexylcarbodiimide (1989) Plant Physiol, 91, pp. 1296-1302Campos, C.B.L., Degasperi, G.R., Pacifico, D.S., Alberici, L.C., Carreira, R.S., Guimaraes, F., Castilho, R.F., Vercesi, A.E., Ibuprofen-induced Walker 256 tumor cell death: Cytochrome c release from functional mitochondria and enhancement by calcineurin inhibition (2004) Biochemical Pharmacology, 68 (11), pp. 2197-2206. , DOI 10.1016/j.bcp.2004.08.006, PII S0006295204005830Figueira, T.R., Melo, D.R., Vercesi, A.E., Castilho, R.F., Safranine as a fluorescent probe for the evaluation of mitochondrial membrane potential in isolated organelles and permeabilized cells (2012) Methods Mol Biol, 810, pp. 103-117Vercesi, A.E., Bernardes, C.F., Hoffmann, M.E., Gadelha, F.R., Docampo, R., Digitonin permeabilization does not affect mitochondrial function and allows the determination of the mitochondrial membrane potential of Trypanosoma cruzi in Situ (1991) Journal of Biological Chemistry, 266 (22), pp. 14431-14434Oliveira, K.A., Zecchin, K.G., Alberici, L.C., Castilho, R.F., Vercesi, A.E., Simvastatin inducing PC3 prostate cancer cell necrosis mediated by calcineurin and mitochondrial dysfunction (2008) J Bioenerg Biomembr, 40, pp. 307-314Sirvent, P., Bordenave, S., Vermaelen, M., Roels, B., Vassort, G., Mercier, J., Raynaud, E., Lacampagne, A., Simvastatin induces impairment in skeletal muscle while heart is protected (2005) Biochemical and Biophysical Research Communications, 338 (3), pp. 1426-1434. , DOI 10.1016/j.bbrc.2005.10.108, PII S0006291X05023600Vercesi, A.E., Rodrigues, C.O., Uyemura, S.A., Zhong, L., Moreno, S.N.J., Respiration and oxidative phosphorylation in the apicomplexan parasite Toxoplasma gondii (1998) Journal of Biological Chemistry, 273 (47), pp. 31040-31047. , DOI 10.1074/jbc.273.47.31040Bligh, E.G., Dyer, W.J., A rapid method of total lipid extraction and purification (1959) Canadian Journal of Biochemistry and Physiology, 37, pp. 911-917Xia, J., Mandal, R., Sinelnikov, I.V., Broadhurst, D., Wishart, D.S., MetaboAnalyst 2.0 - A comprehensive server for metabolomic data analysis (2009) Nucleic Acids Res, 40, pp. W127-W133Xia, J., Psychogios, N., Young, N., Wishart, D.S., MetaboAnalyst: A web server for metabolomic data analysis and interpretation (2009) Nucleic Acids Res, 37, pp. W652-W660Tymianski, M., Charlton, M.P., Carlen, P.L., Tator, C.H., Source specificity of early calcium neurotoxicity in cultured embryonic spinal neurons (1993) Journal of Neuroscience, 13 (5), pp. 2085-2104Komarov, P.G., Komarova, E.A., Kondratov, R.V., Christov-Tselkov, K., Coon, J.S., A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy (1999) Science New York, NY, 285, pp. 1733-1737Figueira, T.R., Barros, M.H., Camargo, A.A., Castilho, R.F., Ferreira, J.C., Mitochondria as a source of reactive oxygen and nitrogen species: From molecular mechanisms to human health (2013) Antioxid Redox Signal, 18, pp. 2029-2074Aruoma, O.I., Halliwell, B., Hoey, B.M., Butler, J., The antioxidant action of N-acetylcysteine: Its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid (1989) Free Radical Biology and Medicine, 6 (6), pp. 593-597. , DOI 10.1016/0891-5849(89)90066-XBalkova, P., Hlavackova, M., Milerova, M., Neckar, J., Kolar, F., N-acetylcysteine treatment prevents the up-regulation of MnSOD in chronically hypoxic rat hearts (2011) Physiol Res, 60, pp. 467-474Mayer, M., Noble, M., N-acetyl-L-cysteine is a pluripotent protector against cell death and enhancer of trophic factor-mediated cell survival in vitro (1994) Proceedings of the National Academy of Sciences of the United States of America, 91, pp. 7496-7500Meister, A., Anderson, M.E., Glutathione (1983) Annual Review of Biochemistry, 52, pp. 711-760Menendez, J.A., Vellon, L., Lupu, R., Antitumoral actions of the anti-obesity drug orlistat (XenicalTM) in breast cancer cells: Blockade of cell cycle progression, promotion of apoptotic cell death and PEA3-mediated transcriptional repression of Her2/neu (erbB-2) oncogene (2005) Annals of Oncology, 16 (8), pp. 1253-1267. , DOI 10.1093/annonc/mdi239Ho, T.-S., Ho, Y.-P., Wong, W.-Y., Chi-Ming, C.L., Wong, Y.-S., Eng-Choon, O.V., Fatty acid synthase inhibitors cerulenin and C75 retard growth and induce caspase-dependent apoptosis in human melanoma A-375 cells (2007) Biomedicine and Pharmacotherapy, 61 (9 SPEC. ISS.), pp. 578-587. , DOI 10.1016/j.biopha.2007.08.020, PII S0753332207001898Menendez, J.A., Vellon, L., Lupu, R., Orlistat: From antiobesity drug to anticancer agent in Her-2/neu (erbB-2)-overexpressing gastrointestinal tumors? (2005) Experimental Biology and Medicine Maywood, NJ, 230, pp. 151-154Hengartner, M.O., The biochemistry of apoptosis (2000) Nature, 407, pp. 770-776Liu, X., Kim, C.N., Yang, J., Jemmerson, R., Wang, X., Induction of apoptotic program in cell-free extracts: Requirement for dATP and cytochrome c (1996) Cell, 86 (1), pp. 147-157. , DOI 10.1016/S0092-8674(00)80085-9Zou, H., Li, Y., Liu, X., Wang, X., An APAF-1.Cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9 (1999) The Journal of Biological Chemistry, 274, pp. 11549-11556Wu, C.C., Bratton, S.B., Regulation of the intrinsic apoptosis pathway by reactive oxygen species (2013) Antioxid Redox Signal, 19, pp. 546-558Chajes, V., Cambot, M., Moreau, K., Lenoir, G.M., Joulin, V., Acetyl-CoA carboxylase alpha is essential to breast cancer cell survival (2006) Cancer Research, 66 (10), pp. 5287-5294. , DOI 10.1158/0008-5472.CAN-05-1489La Guardia, P.G., Alberici, L.C., Ravagnani, F.G., Catharino, R.R., Vercesi, A.E., Protection of rat skeletal muscle fibers by either L-carnitine or coenzyme Q10 against statins toxicity mediated by mitochondrial reactive oxygen generation (2013) Front Physiol, 4, p. 103Panov, A., Dikalov, S., Shalbuyeva, N., Taylor, G., Sherer, T., Greenamyre, J.T., Rotenone model of Parkinson disease: Multiple brain mitochondria dysfunctions after short term systemic rotenone intoxication (2005) Journal of Biological Chemistry, 280 (51), pp. 42026-42035. , DOI 10.1074/jbc.M508628200Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S.M., Ahmad, M., Alnemri, E.S., Wang, X., Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade (1997) Cell, 91 (4), pp. 479-489Coleman, M.L., Sahai, E.A., Yeo, M., Bosch, M., Dewar, A., Olson, M.F., Membrane blebbing during apoptosis results from caspase-mediated activation of ROCK I (2001) Nature Cell Biology, 3 (4), pp. 339-345. , DOI 10.1038/35070009Enari, M., Sakahira, H., Yokoyama, H., Okawa, K., Iwamatsu, A., Nagata, S., A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD (1998) Nature, 391 (6662), pp. 43-50. , DOI 10.1038/34112Kothakota, S., Azuma, T., Reinhard, C., Klippel, A., Tang, J., Caspase-3-generated fragment of gelsolin: Effector of morphological change in apoptosis (1997) Science New York, NY, 278, pp. 294-298Rudel, T., Zenke, F.T., Chuang, T.-H., Bokoch, G.M., p21-activated kinase (PAK) is required for Fas-induced JNK activation in Jurkat cells (1998) Journal of Immunology, 160 (1), pp. 7-11Sahara, S., Aoto, M., Eguchi, Y., Imamoto, N., Yoneda, Y., Tsujimoto, Y., Acinus is a caspase-3-activated protein required for apoptotic chromatin condensation (1999) Nature, 401 (6749), pp. 168-173. , DOI 10.1038/43678Ricci, J.-E., Gottlieb, R.A., Green, D.R., Caspase-mediated loss of mitochondrial function and generation of reactive oxygen species during apoptosis (2003) Journal of Cell Biology, 160 (1), pp. 65-75. , DOI 10.1083/jcb.200208089Ricci, J.-E., Munoz-Pinedo, C., Fitzgerald, P., Bailly-Maitre, B., Perkins, G.A., Yadava, N., Scheffler, I.E., Green, D.R., Disruption of mitochondrial function during apoptosis is mediated by caspase cleavage of the p75 subunit of complex I of the electron transport chain (2004) Cell, 117 (6), pp. 773-786. , DOI 10.1016/j.cell.2004.05.008, PII S0092867404004969